Biocept Stock Price

0.0157 (1.76%)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Biocept Inc BIOC NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.0157 1.76% 0.91 0.00 0.00 0.00 0.8943 06:45:55
Bid Price Ask Price Spread Spread % News
0.91 0.9187 0.0087 0.95% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
109 32,375 $ 0.9088097 $ 29,423 21,437,164 0.2112 - 1.24
Last Trade Time Type Quantity Stock Price Currency
06:45:55 formt 697 $ 0.91 USD

Biocept Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 119.30M 131.10M 130.59M $ 5.53M $ - -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Biocept News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIOC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.66130.94680.6530.798286629,214,9600.248737.61%
1 Month0.73850.94680.640.749188718,162,0560.171523.22%
3 Months0.42131.040.380.684748527,028,0380.4887116.0%
6 Months0.3281.240.21120.587628421,315,5440.582177.44%
1 Year1.031.240.21120.558076512,175,997-0.12-11.65%
3 Years1.4112.150.1410.71124955,262,131-0.50-35.46%
5 Years2.4112.150.1410.80766633,455,131-1.50-62.24%

Biocept Description

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.